Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (161-170 of 778) with videos related to

Pageof 78
Sort By:
Recenti Progressi in Medicina|March 21, 2012
[Clinical decision making in left main coronary artery disease revascularization: the past, present and future]Fabio Dipasqua, Davide Capodanno, Corrado Tamburino
Giornale Italiano Di Cardiologia (2006)|May 31, 2014
[The PRAMI study]Giuseppe Tarantini, Marco Mojoli, Davide Capodanno
European Heart Journal|January 19, 2024
Aspirin-free antiplatelet strategies after percutaneous coronary interventionsPiera Capranzano, David Moliterno, Davide Capodanno
Future Cardiology|October 21, 2017
Hot topics in transcatheter aortic valve implantationMarco Barbanti, Corrado Tamburino, Davide Capodanno
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
Should clopidogrel replace aspirin for long-term therapy after percutaneous coronary intervention?Antonino Imbesi, Luigi Cutore, Davide Capodanno
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Comment on Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularizationJuhani Knuuti, Antti Saraste, Davide Capodanno
Expert Review of Clinical Pharmacology|August 29, 2022
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attackLorenzo Scalia, Dario Calderone, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
What about the risk of thrombosis with bioresorbable scaffolds?Davide Capodanno, Michael Joner, Marco Zimarino
The Canadian Journal of Cardiology|December 15, 2025
Contemporary Controversies Around Medical Ethics of Gene Therapy for Cardiovascular DiseaseAntonio Greco, Luigi Cutore, Davide Capodanno
International Journal of Cardiology|May 21, 2011
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global RiskDavide Capodanno, Piera Capranzano, Corrado Tamburino
Pageof 78

Showing results (161-170 of 778) with videos related to

Sort By:
Pageof 78
Recenti Progressi in Medicina|March 21, 2012
[Clinical decision making in left main coronary artery disease revascularization: the past, present and future]Fabio Dipasqua, Davide Capodanno, Corrado Tamburino
Giornale Italiano Di Cardiologia (2006)|May 31, 2014
[The PRAMI study]Giuseppe Tarantini, Marco Mojoli, Davide Capodanno
European Heart Journal|January 19, 2024
Aspirin-free antiplatelet strategies after percutaneous coronary interventionsPiera Capranzano, David Moliterno, Davide Capodanno
Future Cardiology|October 21, 2017
Hot topics in transcatheter aortic valve implantationMarco Barbanti, Corrado Tamburino, Davide Capodanno
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
Should clopidogrel replace aspirin for long-term therapy after percutaneous coronary intervention?Antonino Imbesi, Luigi Cutore, Davide Capodanno
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2022
Comment on Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularizationJuhani Knuuti, Antti Saraste, Davide Capodanno
Expert Review of Clinical Pharmacology|August 29, 2022
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attackLorenzo Scalia, Dario Calderone, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2015
What about the risk of thrombosis with bioresorbable scaffolds?Davide Capodanno, Michael Joner, Marco Zimarino
The Canadian Journal of Cardiology|December 15, 2025
Contemporary Controversies Around Medical Ethics of Gene Therapy for Cardiovascular DiseaseAntonio Greco, Luigi Cutore, Davide Capodanno
International Journal of Cardiology|May 21, 2011
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global RiskDavide Capodanno, Piera Capranzano, Corrado Tamburino
Pageof 78